workforce news

PCOS and the Pharmacy: What Pharmacists Can Advise

Polycystic ovary syndrome affects an estimated one in ten women in the UK — community pharmacists are often the first point of contact for symptom management.

By PharmSee · · 1 views

Polycystic ovary syndrome (PCOS) is one of the most common endocrine conditions affecting women of reproductive age. According to NICE Clinical Knowledge Summaries, it affects an estimated 8–13% of women in the UK, though many cases remain undiagnosed. Community pharmacists encounter PCOS through multiple touchpoints — from dispensing metformin and combined oral contraceptives to advising on over-the-counter products for acne and excess hair growth.

Understanding PCOS

PCOS is characterised by a combination of features: irregular or absent periods, elevated androgen levels (causing acne, hirsutism, or hair thinning), and polycystic ovaries on ultrasound. A diagnosis requires at least two of these three features under the Rotterdam criteria, after other causes have been excluded.

The condition has metabolic implications beyond its reproductive effects. Women with PCOS have an increased lifetime risk of type 2 diabetes, cardiovascular disease, and endometrial hyperplasia. This metabolic dimension is why many women with PCOS are prescribed metformin — a medicine most commonly associated with diabetes management.

What brings PCOS patients to the pharmacy

Reason for pharmacy visitWhat the pharmacist can do
Collecting metformin prescriptionCounsel on GI side effects, modified-release formulations, importance of adherence
Collecting combined oral contraceptiveExplain that the pill regulates periods and reduces androgen effects, not just contraception
OTC acne productsAdvise on benzoyl peroxide, salicylic acid; identify when prescription-strength treatment is needed
Hair removal productsAdvise on depilatory creams, suggest eflornithine cream (prescription only) discussion with GP
Weight managementProvide evidence-based advice on diet and physical activity; signpost to NHS weight management services
Fertility concernsExplain that PCOS is a common cause of anovulatory infertility and encourage GP referral

Pharmacy-available products for PCOS symptoms

Acne

PCOS-related acne is typically hormonal — concentrated on the jawline and lower face. Pharmacy options include:

  • Benzoyl peroxide (2.5–10%): available as gels and washes without prescription. Effective as a first-line treatment for mild-to-moderate acne.
  • Salicylic acid cleansers and spot treatments: available OTC, useful as adjunct therapy.
  • Nicotinamide gel (4%): a lesser-known but evidence-supported OTC option with anti-inflammatory properties.

For moderate-to-severe PCOS acne, pharmacists should recommend GP referral for topical retinoids, topical antibiotics, or the combined oral contraceptive pill (co-cyprindiol or other anti-androgenic formulations).

Hirsutism

Excess facial and body hair is one of the most distressing symptoms reported by women with PCOS. OTC options are limited to physical removal methods (shaving, waxing, depilatory creams, epilators). Eflornithine cream (Vaniqa), which slows facial hair growth, is prescription-only in the UK.

Pharmacists can provide empathetic, practical advice: physical removal is safe and does not worsen hair growth (a persistent myth), and for significant hirsutism, GP referral for eflornithine or anti-androgen medication is appropriate.

Weight management

Between 40% and 80% of women with PCOS are overweight or obese, according to published estimates. Even modest weight loss (5–10% of body weight) can improve menstrual regularity, reduce androgen levels, and improve insulin sensitivity. Pharmacists can signpost to the NHS Digital Weight Management Programme and advise on calorie-controlled diets and the role of physical activity.

Dispensing considerations

Metformin

Metformin is commonly prescribed for PCOS even in non-diabetic women, as it improves insulin sensitivity and can help with weight management and menstrual regularity. NICE recommends metformin as second-line treatment for menstrual irregularity where lifestyle changes have been insufficient.

Key dispensing points:

  • Gastrointestinal side effects (nausea, diarrhoea) are common, particularly with immediate-release formulations. Modified-release tablets are better tolerated.
  • Patients should be advised to take metformin with or after food.
  • Metformin is not licensed for PCOS in the UK — it is used off-label. Patients may be confused when the PIL references diabetes but not PCOS.

Combined oral contraceptives

The combined pill is first-line for managing menstrual irregularity and hyperandrogenism in PCOS. Co-cyprindiol (Dianette) contains cyproterone acetate, a potent anti-androgen, but carries a higher venous thromboembolism risk than other COCs and is typically reserved for women with significant acne or hirsutism.

Spironolactone

Spironolactone (off-label) is sometimes prescribed for hirsutism and acne in PCOS. It is a potassium-sparing diuretic with anti-androgen properties. Pharmacists should counsel on the need for reliable contraception (spironolactone is teratogenic) and the possibility of hyperkalaemia if combined with other potassium-elevating medicines.

When to refer

Pharmacists should recommend GP referral when a woman presents with:

  • Irregular or absent periods lasting more than three months
  • Significant acne unresponsive to OTC treatment
  • Noticeable excess hair growth or scalp hair thinning
  • Difficulty conceiving after 12 months of trying
  • Symptoms of depression or anxiety related to PCOS

PCOS is a long-term condition that benefits from coordinated care. Community pharmacists, as the most frequently visited healthcare professionals, are well placed to support ongoing symptom management, medication adherence, and timely referral.

Explore pharmacy services near you or check pharmacy career opportunities on PharmSee.


Sources: NICE CKS Polycystic Ovary Syndrome, Rotterdam criteria, BNF monographs for metformin/co-cyprindiol/spironolactone, DHSC Women's Health Strategy 2026 renewal, PharmSee vacancy database (1,742 active roles as of April 2026).